Dermapharm Holding SE Announces Share Buyback Offer

Dermapharm Holding SE has announced a public share buyback offer for up to 4,300,000 shares, which represents approximately 7.99% of the company's share capital. The offer price is set at EUR 42.00 per share. The board's decision, approved by the Supervisory Board, follows authorization by the Annual General Meeting held on 14 June 2023.

The buyback's acceptance period starts on 11 March 2026 and is scheduled to end on 24 March 2026, with a possible extension. If more shares are tendered than the buyback limit, acceptance will be determined on a pro-rata basis. The repurchased shares are set to be canceled.

Details of the offer are available on Dermapharm's website and in the Federal Gazette. Communication restrictions apply, as distribution in certain countries like the USA, Canada, Australia, and Japan is prohibited due to legal constraints.